Your browser doesn't support javascript.
loading
Associations between sex, body mass index and the individual microglial response in Alzheimer's disease.
Biechele, Gloria; Rauchmann, Boris-Stephan; Janowitz, Daniel; Buerger, Katharina; Franzmeier, Nicolai; Weidinger, Endy; Guersel, Selim; Schuster, Sebastian; Finze, Anika; Harris, Stefanie; Lindner, Simon; Albert, Nathalie L; Wetzel, Christian; Rupprecht, Rainer; Rominger, Axel; Palleis, Carla; Katzdobler, Sabrina; Burow, Lena; Kurz, Carolin; Zaganjori, Mirlind; Trappmann, Lena-Katharina; Goldhardt, Oliver; Grimmer, Timo; Haeckert, Jan; Keeser, Daniel; Stoecklein, Sophia; Morenas-Rodriguez, Estrella; Bartenstein, Peter; Levin, Johannes; Höglinger, Günter U; Simons, Mikael; Perneczky, Robert; Brendel, Matthias.
Afiliación
  • Biechele G; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Rauchmann BS; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Janowitz D; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Buerger K; Institute of Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Franzmeier N; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
  • Weidinger E; Institute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
  • Guersel S; Institute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
  • Schuster S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Finze A; Institute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
  • Harris S; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Lindner S; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Gothenburg, Sweden.
  • Albert NL; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Wetzel C; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Rupprecht R; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Rominger A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Palleis C; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Katzdobler S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Burow L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Kurz C; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
  • Zaganjori M; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
  • Trappmann LK; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Goldhardt O; Department of Nuclear Medicine, University of Bern, Inselspital, Bern, Switzerland.
  • Grimmer T; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Haeckert J; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Keeser D; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Stoecklein S; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Morenas-Rodriguez E; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Bartenstein P; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, University of Munich, Marchioninstraße 15, 81377, Munich, Germany.
  • Levin J; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Höglinger GU; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
  • Simons M; Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
  • Perneczky R; Department of Psychiatry and Psychotherapy, School of Medicine and Health, Technical University Munich, Klinikum Rechts Der Isar, Munich, Germany.
  • Brendel M; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Augsburg, Germany.
J Neuroinflammation ; 21(1): 30, 2024 Jan 23.
Article en En | MEDLINE | ID: mdl-38263017
ABSTRACT
BACKGROUND AND

OBJECTIVES:

18-kDa translocator protein position-emission-tomography (TSPO-PET) imaging emerged for in vivo assessment of neuroinflammation in Alzheimer's disease (AD) research. Sex and obesity effects on TSPO-PET binding have been reported for cognitively normal humans (CN), but such effects have not yet been systematically evaluated in patients with AD. Thus, we aimed to investigate the impact of sex and obesity on the relationship between ß-amyloid-accumulation and microglial activation in AD.

METHODS:

49 patients with AD (29 females, all Aß-positive) and 15 Aß-negative CN (8 female) underwent TSPO-PET ([18F]GE-180) and ß-amyloid-PET ([18F]flutemetamol) imaging. In 24 patients with AD (14 females), tau-PET ([18F]PI-2620) was additionally available. The brain was parcellated into 218 cortical regions and standardized-uptake-value-ratios (SUVr, cerebellar reference) were calculated. Per region and tracer, the regional increase of PET SUVr (z-score) was calculated for AD against CN. The regression derived linear effect of regional Aß-PET on TSPO-PET was used to determine the Aß-plaque-dependent microglial response (slope) and the Aß-plaque-independent microglial response (intercept) at the individual patient level. All read-outs were compared between sexes and tested for a moderation effect of sex on associations with body mass index (BMI).

RESULTS:

In AD, females showed higher mean cortical TSPO-PET z-scores (0.91 ± 0.49; males 0.30 ± 0.75; p = 0.002), while Aß-PET z-scores were similar. The Aß-plaque-independent microglial response was stronger in females with AD (+ 0.37 ± 0.38; males with AD - 0.33 ± 0.87; p = 0.006), pronounced at the prodromal stage. On the contrary, the Aß-plaque-dependent microglial response was not different between sexes. The Aß-plaque-independent microglial response was significantly associated with tau-PET in females (Braak-II regions r = 0.757, p = 0.003), but not in males. BMI and the Aß-plaque-independent microglial response were significantly associated in females (r = 0.44, p = 0.018) but not in males (BMI*sex interaction F(3,52) = 3.077, p = 0.005).

CONCLUSION:

While microglia response to fibrillar Aß is similar between sexes, women with AD show a stronger Aß-plaque-independent microglia response. This sex difference in Aß-independent microglial activation may be associated with tau accumulation. BMI is positively associated with the Aß-plaque-independent microglia response in females with AD but not in males, indicating that sex and obesity need to be considered when studying neuroinflammation in AD.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microglía / Enfermedad de Alzheimer Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microglía / Enfermedad de Alzheimer Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania